202 related articles for article (PubMed ID: 35439028)
41. High mortality in hematopoietic stem cell transplant-associated thrombotic microangiopathy with and without concomitant acute graft-versus-host disease.
Kraft S; Bollinger N; Bodenmann B; Heim D; Bucher C; Lengerke C; Kleber M; Tsakiris DA; Passweg J; Tzankov A; Medinger M
Bone Marrow Transplant; 2019 Apr; 54(4):540-548. PubMed ID: 30108323
[TBL] [Abstract][Full Text] [Related]
42. Diagnosis of intestinal graft-versus-host disease and thrombotic microangiopathy after allogeneic stem cell transplantation.
Yamada-Fujiwara M; Miyamura K; Fujiwara T; Tohmiya Y; Endo K; Onishi Y; Ishizawa K; Kameoka J; Ito M; Harigae H
Tohoku J Exp Med; 2012 May; 227(1):31-7. PubMed ID: 22531159
[TBL] [Abstract][Full Text] [Related]
43. [Clinical analysis of 9 patients with transplant-related thrombotic microangiopathy].
Zhang BL; Zhou J; Gui RR; Zu YL; Zhang YL; Song YP
Zhonghua Nei Ke Za Zhi; 2019 Jun; 58(6):423-427. PubMed ID: 31159520
[No Abstract] [Full Text] [Related]
44. A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury.
Jodele S; Laskin BL; Dandoy CE; Myers KC; El-Bietar J; Davies SM; Goebel J; Dixon BP
Blood Rev; 2015 May; 29(3):191-204. PubMed ID: 25483393
[TBL] [Abstract][Full Text] [Related]
45. Hematopoietic stem cell transplantation-associated thrombotic microangiopathy accompanied by renal arteriolar C4d deposition.
Sakamoto K; Imamura T; Osone S; Nishimura A; Nishida M; Ishida H; Hosoi H
Pediatr Transplant; 2015 Jun; 19(4):E97-100. PubMed ID: 25735190
[TBL] [Abstract][Full Text] [Related]
46. Successful use of narsoplimab to treat allogeneic transplant-associated thrombotic microangiopathy while maintaining sirolimus.
Alhomoud M; Scordo M; Perales MA
Bone Marrow Transplant; 2024 Jun; 59(6):904-906. PubMed ID: 38467748
[No Abstract] [Full Text] [Related]
47. Impact of treatment and outcomes for patients with posttransplant drug-associated thrombotic microangiopathy.
Epperla N; Hemauer K; Hamadani M; Friedman KD; Kreuziger LB
Transfusion; 2017 Nov; 57(11):2775-2781. PubMed ID: 28836275
[TBL] [Abstract][Full Text] [Related]
48. The Role of Complement in HSCT-TMA: Basic Science to Clinical Practice.
Meri S; Bunjes D; Cofiell R; Jodele S
Adv Ther; 2022 Sep; 39(9):3896-3915. PubMed ID: 35781192
[TBL] [Abstract][Full Text] [Related]
49. Approaching treatment of transplant-associated thrombotic Microangiopathy from two directions with Eculizumab and transitioning from Tacrolimus to Sirolimus.
Jan AS; Hosing C; Aung F; Yeh J
Transfusion; 2019 Nov; 59(11):3519-3524. PubMed ID: 31587288
[TBL] [Abstract][Full Text] [Related]
50. New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy.
Jodele S; Dandoy CE; Myers KC; El-Bietar J; Nelson A; Wallace G; Laskin BL
Transfus Apher Sci; 2016 Apr; 54(2):181-90. PubMed ID: 27156964
[TBL] [Abstract][Full Text] [Related]
51. Eculizumab precision-dosing algorithm for thrombotic microangiopathy in children and young adults undergoing HSCT.
Mizuno K; Dandoy CE; Teusink-Cross A; Davies SM; Vinks AA; Jodele S
Blood Adv; 2022 Mar; 6(5):1454-1463. PubMed ID: 35008105
[TBL] [Abstract][Full Text] [Related]
52. Use of Eculizumab in Thrombotic Microangiopathy Associated with Hematopoietic Stem Cell Transplantation.
Demircioglu S; Dogan A; Demir C
J Coll Physicians Surg Pak; 2021 Nov; 31(11):1359-1361. PubMed ID: 34689499
[TBL] [Abstract][Full Text] [Related]
53. Short Course of Eculizumab May Be Effective in Dialysis-Dependent Transplantation-Associated Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplantation: A Case Report.
Jarmoliński T; Rosa M; Puziewicz-Zmonarska A; Kałwak K
Transplant Proc; 2020 Oct; 52(8):2544-2547. PubMed ID: 32917392
[TBL] [Abstract][Full Text] [Related]
54. Renal thrombotic microangiopathy associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Mii A; Shimizu A; Kaneko T; Fujita E; Fukui M; Fujino T; Utsumi K; Yamaguchi H; Tajika K; Tsuchiya S; Iino Y; Katayama Y; Fukuda Y
Pathol Int; 2011 Sep; 61(9):518-27. PubMed ID: 21884301
[TBL] [Abstract][Full Text] [Related]
55. Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus.
Labrador J; López-Corral L; López-Godino O; Vázquez L; Cabrero-Calvo M; Pérez-López R; Díez-Campelo M; Sánchez-Guijo F; Pérez-López E; Guerrero C; Alberca I; Del Cañizo MC; Pérez-Simón JA; González-Porras JR; Caballero D
Bone Marrow Transplant; 2014 May; 49(5):684-90. PubMed ID: 24566710
[TBL] [Abstract][Full Text] [Related]
56. Abnormal echocardiography 7 days after stem cell transplantation may be an early indicator of thrombotic microangiopathy.
Dandoy CE; Davies SM; Hirsch R; Chima RS; Paff Z; Cash M; Ryan TD; Lane A; El-Bietar J; Myers KC; Jodele S
Biol Blood Marrow Transplant; 2015 Jan; 21(1):113-8. PubMed ID: 25300868
[TBL] [Abstract][Full Text] [Related]
57. Two cases of kidney transplantation-associated thrombotic microangiopathy successfully treated with eculizumab.
Ikeda T; Okumi M; Unagami K; Kanzawa T; Sawada A; Kawanishi K; Omoto K; Ishida H; Tanabe K
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():35-40. PubMed ID: 26970541
[TBL] [Abstract][Full Text] [Related]
58. Idiopathic pneumonia syndrome with thrombotic microangiopathy-related changes after allogeneic hematopoietic stem cell transplantation.
Nakamura Y; Mitani N; Ishii A; Hayashi S; Yujiri T; Ikeda E; Tanizawa Y
Int J Hematol; 2013 Oct; 98(4):496-8. PubMed ID: 23955112
[TBL] [Abstract][Full Text] [Related]
59. Thrombotic microangiopathy in haematopoietic stem cell transplantation: diagnosis and treatment.
Choi CM; Schmaier AH; Snell MR; Lazarus HM
Drugs; 2009; 69(2):183-98. PubMed ID: 19228075
[TBL] [Abstract][Full Text] [Related]
60. The Role of Complement Activating Collectins and Associated Serine Proteases in Patients With Hematological Malignancies, Receiving High-Dose Chemotherapy, and Autologous Hematopoietic Stem Cell Transplantations (Auto-HSCT).
Świerzko AS; Michalski M; Sokołowska A; Nowicki M; Eppa Ł; Szala-Poździej A; Mitrus I; Szmigielska-Kapłon A; Sobczyk-Kruszelnicka M; Michalak K; Gołos A; Wierzbowska A; Giebel S; Jamroziak K; Kowalski ML; Brzezińska O; Thiel S; Jensenius JC; Kasperkiewicz K; Cedzyński M
Front Immunol; 2018; 9():2153. PubMed ID: 30294330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
